Services commerciaux et administratifs
14 rue de provigny
94236 Cachan Cedex France
Tél. : +33 (0)1 47 40 67 00
Fax : +33 (0)1 47 40 67 91
Email : infos@datec.lavoisier.fr

Le site de préparation au TOEIC pour les francophones bandeau Pharmacopée européenne démonstration de la plateforme numérique de Vocable bandeau AAOS bandeau Micromedex bandeau Rightanswer bandeau Springer

Fiche descriptive

element de separation

Ensemble

Je teste cette ressource électronique

Éditeur : Prous Science

Support : Internet

Catégorie :

Pharmacie, pharmacologie

Langue : Anglais

Type de ressource : Texte intégral, image…

Nombre de données : Plus de 140 000 composés bioactives, 335 000 references et 43 000 familles de brevets

Sujet(s) : Recherche et développement pharmaceutique : structures chimiques de médicaments…

Résumé:

Ensemble® on the Web provides essential information, including chemical structures, on more than 140,000 bioactive compounds in the drug research and development pipeline. The database integrates data, text and image management in a user-friendly environment. Ensemble® tracks drugs from their first public mention in the patent literature through preclinical and clinical trials to registration, marketing and beyond.

Information provided for compounds in the Ensemble® database includes: molecular formula; chemical names; company codes; generic names; trademarks; industrial or other sources; licensees; pharmacotherapeutic activity and mechanism(s) of action; development phase; CAS® Registry Number; patent information (titles, inventors, applicants, numbers and publication dates, priority numbers and publication dates); literature references (authors, titles, publications), including references to the Prous Science journals and to the Prous Science Daily Essentials drug news alerting service; and the chemical structure. Coming soon: Detailed pipeline information and product development milestones.

The Development Pipeline shows a compound's current development phase in a given country or area and correlates this information to indication, organization and brand name. Milestones-past and future-are provided (where available) for individual Pipeline entries. Milestones trace the progress of a drug from phase to phase during the development cycle and cite developer forecasts for the timing of future events (e.g., targeted registration and launch dates for compounds currently in development).

  • Comprehensive coverage of drug information through all phases of discovery, development and marketing worldwide.
  • More than 140,000 compounds with demonstrated biological activity, more than 335,000 references to the biomedical and congress literature; more than 43,000 patent families cited.
  • Extensive patent, literature and congress references linked to compounds.
  • Full drug monographs and schemes of synthesis for compounds in later stages of development.
  • User-friendly menu-based interface with practical browse indices for developing targeted search strategies.
  • Query Manager to save and re-use strategies with new releases.
  • Display Statistics feature classifies and ranks data instantaneously to facilitate analysis.

Je teste gratuitement et sans engagement Ensemble

© 2017 Lavoisier-Datec